Neil Schauer, PhD joins Hospira as Senior Director, Biologics Process Development

Life Science Partner recruits former Director of DSP Research and Development at Millipore Corp

Life Science Partner announces the recruitment of Neil Schauer, PhD, a seasoned biopharmaceutical development leader and scientist, to become Senior Director, Biologics Development for Hospira’s biosimilars division.  Hospira is a global specialty pharmaceutical and medication delivery company that develops, manufactures and markets products that help improve the safety, effectiveness and costs of patient care.

In his most recent role at Millipore Corp, Schauer was responsible for scientific and managerial leadership of a large research and development organization with four functional areas focusing on DSP Research.  Prior to his tenure at Millipore Corp, Schauer served as the Director of Cambridge Manufacturing Sciences at Biogen Idec.  In his new role at Hospira, he will have overall responsibility for providing strategic and technical leadership to a large staff of pharmaceutical scientists responsible for the development of Drug Substance and Drug Product manufacturing for Hospira’s biosimilar products.

“Schauer is a versatile leader and scientist with a solid background in managing large teams in the identification and development of disruptive new technologies” noted Tom Callaway, MD, Founder and President of Life Science Partner.  “With his global knowledge and reach, he will serve Hospira well in its mission to become a global leader in providing biosimilar versions of the world’s most critical biological drugs.”

Schauer earned a Bachelor of Science in Biochemistry and Biology and his PhD in Anaerobic Microbiology from the Virginia Polytechnic Institute, Blacksburg.